Akari Therapeutics Plc - ADR

XNAS:AKTX 4:00:00 PM EDT

4.47

-0.18 (-3.87%)

6:49:44 PM EDT: $4.77 +0.30 (+6.71%)

Akari Therapeutics Plc - ADR Stock, XNAS:AKTX

22 Boston Wharf Road, 7th Floor, Boston, Massachusetts 02210

United States of America

Phone: +1.929.274.7510

Number of Employees:

http://www.akaritx.com

Description

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.